Neonatal period: body composition changes in breast-fed full-term newborns

Paola Roggero1, Maria L Giannì, Anna Orsi

  • 1Neonatal Intensive Care Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy. roggero@unimi.it

Neonatology
|September 25, 2009
PubMed

Insights

Newborns lose both fat mass and fat-free mass in the first few days of life, with fat mass being regained more rapidly. This study clarifies infant body composition changes during early postnatal development.

Area of Science:

  • Neonatal physiology
  • Infant body composition analysis
  • Pediatric research

Background:

  • Newborn infants typically experience weight loss in the initial days of life.
  • This weight loss involves both body solids and total body water.
  • The precise nature of these early body composition changes requires detailed investigation.

Purpose of the Study:

  • To investigate the specific changes in body composition during the period of weight loss in healthy term newborns.
  • To differentiate between fat mass and fat-free mass changes in early infancy.

Main Methods:

  • Utilized air-displacement plethysmography to assess body composition in healthy full-term newborns.
  • Employed both cross-sectional (n=262) and longitudinal (n=28) study designs.
  • Data collection occurred during the first 4-5 days after delivery.

Main Results:

  • Significant decreases in body weight, fat mass (FM), and %FM were observed by day 3-4 in cross-sectional and longitudinal samples.
  • Fat-free mass also significantly decreased on days 3 and 4.
  • By day 5, significant regain of body weight, FM, and %FM was noted compared to day 4, with no significant difference from day 1.

Conclusions:

  • Body composition changes in early infancy involve reductions in both fat mass and fat-free mass.
  • Fat mass experiences a proportionally greater loss and subsequent regain by day 5 compared to fat-free mass.
  • These findings provide insight into the dynamic nature of infant body composition post-birth.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...